Central nervous system manifestations in rheumatic diseases

Area of Science:

• Rheumatology
• Neurology
• Immunology

Background:

• The role of neurologists in rheumatic disease management is growing.
• Central nervous system (CNS) involvement is a significant complication of autoimmune rheumatic disorders.
• Collaboration between rheumatologists and neurologists is essential.

Purpose of the Study:

• To review CNS manifestations in major autoimmune rheumatic diseases.
• To highlight the link between autoimmune markers, systemic inflammation, and neural injury.
• To emphasize the importance of recognizing therapy-related neurological adverse events.

Main Methods:

• Literature review of central nervous system manifestations in autoimmune rheumatic diseases.
• Analysis of novel findings on autoimmune markers and CNS damage.
• Discussion of neurological adverse events associated with biological therapies.

Main Results:

• Common CNS manifestations include stroke, meningoencephalitis, meningitis, myelopathies, psychosis, chorea, seizures, and headaches.
• Specific autoimmune markers are directly linked to CNS damage, indicating a significant inflammatory component.
• Neurological symptoms can arise from biological therapies, requiring careful assessment.

Conclusions:

• Effective management of rheumatic diseases requires addressing CNS involvement.
• A multidisciplinary approach involving rheumatologists and neurologists is crucial for optimal patient care.
• Further understanding of the neuro-rheumatic interface will improve patient outcomes.